等待开盘 08-14 09:30:00 美东时间
+0.260
+3.42%
Webcast link can be found under Investor Relations/Events section of Arcturus’ website.
07-21 04:06
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is collaborating with Thermo Fisher Scientific Inc. (NYSE:TMO) to support the Phase 3 development and potential commercialization of ARCT-032, the company’s investigational messenger RNA therapy for cystic fibrosis. Read Also: Thermo Fisher Flags 'Mo...
07-02 23:32
Freedom Broker analyst Ilya Zubkov initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and announces Price Target of $27.
07-02 17:47
Arcturus Therapeutics (($ARCT)) has held its Q1 earnings call. Read on for the ...
05-09 09:17
Arcturus Therapeutics Holdings shares are trading lower after the company repor...
05-08 05:08
Cathie Wood’s ARK Invest funds executed a broad rotation across technology, healthcare, and industrial names during the last week while markets remained volatile over broader geopolitical tensions bet...
04-13 19:02
Cathie Wood’s ARK Invest actively rotated out of large-cap technology, crypto-linked equities, and consumer internet names during the last week, while only selectively adding a few names. The firm’s...
03-31 18:35
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31